Charles Theuer, President & CEO, Director at TRACON Pharmaceuticals, holds 406.42K shares in TRACON Pharmaceuticals (Ticker: TCON), holds 14.68K shares in Oncternal Therapeutics (Ticker: ONCT), holds ― shares in 4D Molecular Therapeutics (Ticker: FDMT).
What is the percentage of profitable transactions made by Charles Theuer?
The percentage of profitable transactions made by Charles Theuer is 30%.
What is the average return per transaction made by Charles Theuer?
The average return per transaction made by Charles Theuer is 38.60%.
What stocks does Charles Theuer hold?
Charles Theuer holds: TCON, ONCT, FDMT stocks.
What was Charles Theuer’s latest transaction?
Charles Theuer latest transaction was an Uninformative Buy of $910.00.
What was Charles Theuer's most profitable transaction?
Charles Theuer’s most profitable transaction was an Informative Buy of TCON stock on March 13, 2020. The return on the trade was 750.40%.
What is Charles Theuer's role in TRACON Pharmaceuticals?
Charles Theuer's role in TRACON Pharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.